Evidence map›Paper›PMID 37189346›Full record

SynthesisBiomolecules2023

A Systematic Review on Dementia and Translocator Protein (TSPO): When Nuclear Medicine Highlights an Underlying Expression.

Miriam Conte, Maria Silvia De Feo, Ferdinando Corica, Joana Gorica, Marko Magdi Abdou Sidrak, Flaminia De Cristofaro, Luca Filippi, Maria Ricci, Giuseppe De Vincentis, Viviana Frantellizzi

Abstract readSystematic Review
In one paragraph

Synthesis in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Miriam ConteDepartment of Radiological Sciences, Oncology and Anatomo-Pathology, Sapienza, University of Rome, 00161 Rome, Italy.ORCID 0000-0002-1677-4858
Maria Silvia De FeoDepartment of Radiological Sciences, Oncology and Anatomo-Pathology, Sapienza, University of Rome, 00161 Rome, Italy.
Ferdinando CoricaDepartment of Radiological Sciences, Oncology and Anatomo-Pathology, Sapienza, University of Rome, 00161 Rome, Italy.
Joana GoricaDepartment of Radiological Sciences, Oncology and Anatomo-Pathology, Sapienza, University of Rome, 00161 Rome, Italy.
Marko Magdi Abdou SidrakDepartment of Radiological Sciences, Oncology and Anatomo-Pathology, Sapienza, University of Rome, 00161 Rome, Italy.
Flaminia De CristofaroDepartment of Radiological Sciences, Oncology and Anatomo-Pathology, Sapienza, University of Rome, 00161 Rome, Italy.
Luca FilippiDepartment of Nuclear Medicine, Santa Maria Goretti Hospital, 04100 Latina, Italy.ORCID 0000-0003-4423-5496
Maria RicciNuclear Medicine Unit, Cardarelli Hospital, 86100 Campobasso, Italy.ORCID 0000-0002-9277-6337
Giuseppe De VincentisDepartment of Radiological Sciences, Oncology and Anatomo-Pathology, Sapienza, University of Rome, 00161 Rome, Italy.ORCID 0000-0003-4690-1528
Viviana FrantellizziDepartment of Radiological Sciences, Oncology and Anatomo-Pathology, Sapienza, University of Rome, 00161 Rome, Italy.ORCID 0000-0003-3497-4236

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTranslocator protein (TSPO) is a neuroinflammation hallmark. Different TSPO affinity compounds have been produced and over time, the techniques of radiolabeling have been refined. The aim of this systematic review is to summarize the development of new radiotracers for dementia and neuroinflammation imaging.

methodsAn online search of the literature was conducted in the PubMed, Scopus, Medline, Cochrane Library, and Web of Science databases, selecting published studies from January 2004 to December 2022. The accepted studies considered the synthesis of TSPO tracers for nuclear medicine imaging in dementia and neuroinflammation.

resultsA total of 50 articles was identified. Twelve papers were selected from the included studies' bibliographies and 34 were excluded. Thus, 28 articles were ultimately selected for quality assessment.

conclusionHuge efforts in developing specific and stable tracers for PET/SPECT imaging have been made. The long half-life of

Indexed as

DementiaMolecular ImagingNeuroinflammatory DiseasesPositron-Emission TomographyRadiopharmaceuticalsReceptors, GABA-ATomography, Emission-Computed, Single-PhotonAnimalsCerebellumFluorine RadioisotopesHumansNuclear MedicineReceptors, GABAFluorine-18Fluorine RadioisotopesRadiopharmaceuticalsReceptors, GABAReceptors, GABA-ATSPO protein, humandementianeuroinflammationPBRPETSPECTTSPO

Identifiers

PMID37189346
PMCPMC10136175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.